Introduction by the CEO of the Mepha Group

Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way.
 
This is achieved by team work and innovative spirit, examples of which are as follows.

• Our innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment.
• We have been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease.
• We can offer many creative services and target-oriented two-way communication to help our clients in the treatment of their patients.

Our highly motivated employees add their friendly approach to our comprehensive portfolio for the benefit of our clients.

With best wishes,
Dr. Thomas Villiger